PS
Pravin Samat Teraiya
About Pravin Samat Teraiya
Data last updated:
Pravin Samat Teraiya is a Director at Chevron Pharma Private Limited (since 2010). The company operates in Pharma. Chevron Pharma Private Limited reported revenue of ₹9.69 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Chevron Pharma Private Limited U24100GJ2010PTC061749 | Director | 28 Dec 2010 | 2010 | ₹9.69 Cr (FY 2025) | Active |
Board colleagues of Pravin Samat Teraiya
| Name | DIN | Company | Designation |
|---|---|---|---|
| Harshaben Mahesh Jakasaniya | 01361278 | Chevron Pharma Private Limited | Director |
| Karan Maheshkumar Jakasaniya | 08086213 | Chevron Pharma Private Limited | Director |
| Rameshbhai Devjibhai Gabani | 00106403 | Chevron Pharma Private Limited | Director |
| Umesh Mavjibhai Mendapara | 01228011 | Chevron Pharma Private Limited | Director |
| Uramilaben Pravinbhai Teraiya | 03358024 | Chevron Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Pravin Samat Teraiya
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pravin Samat Teraiya
Pravin Samat Teraiya currently holds 1 directorship: Chevron Pharma Private Limited (Director, since 28 Dec 2010, revenue ₹9.69 Cr (FY 2025)).
Pravin Samat Teraiya was first appointed on 28 Dec 2010 as Director at Chevron Pharma Private Limited.
The current boards of Pravin Samat Teraiya's companies include Harshaben Mahesh Jakasaniya (Chevron Pharma Private Limited), Karan Maheshkumar Jakasaniya (Chevron Pharma Private Limited), Rameshbhai Devjibhai Gabani (Chevron Pharma Private Limited), Umesh Mavjibhai Mendapara (Chevron Pharma Private Limited), Uramilaben Pravinbhai Teraiya (Chevron Pharma Private Limited).